Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nipsnap homolog 3A (NIPSNAP3A) is a member of the NIPSNAP protein family, characterized by the presence of two highly conserved NIPSNAP domains per protein. Unlike NIPSNAP1 and NIPSNAP2, which are more highly studied and linked to functions such as mitochondrial metabolism and mitophagy, NIPSNAP3A—along with its paralog NIPSNAP4—is less well characterized. Limited experimental evidence suggests NIPSNAP3A may be involved in vesicular transport and protein-protein interactions, specifically with inhibitor of apoptosis proteins, indicating a possible role in apoptosis regulation[2][3]. There is currently no substantial evidence for NIPSNAP3A as a direct therapeutic target, nor are there known drugs or established disease biomarkers for this protein[1][3]. NIPSNAP3A is primarily classified as an intracellular protein with low tissue specificity in most datasets[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nipsnap homolog 3A (NIPSNAP3A).